Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma

Chemistry

• Acetonitrile 25%
• Ammonium Acetate 25%
• Antilipemic Agent 12%
• Chloroform 25%
• Lecithin 100%
• Lysophosphatidic Acid 12%
• Lysophosphatidylcholine 25%
• Methanol 25%
• Mobile Phase Composition 25%
• Phosphatidylethanolamine 25%
• Phosphatidylglycerol 12%
• Phosphatidylinositol 25%
• Phosphatidylserine 12%
• Plasma Level 12%
• Quadrupole Time-of-Flight Mass Spectrometry 12%
• Retention Time 100%
• Rosuvastatin 100%
• Salting Out 12%
• Sodium Chloride 12%
• Solvent Extraction 12%
• Sphingomyelin 25%
• Triacylglycerol 25%
• Ultra Performance Liquid Chromatography 12%

Biochemistry, Genetics and Molecular Biology

• Biomembrane 9%
• Blood Level 9%
• Blood Plasma 100%
• Chloroform 18%
• Drug Response 18%
• Lecithin 100%
• Lipid 100%
• Liquid Liquid Extraction 9%
• Lysophosphatidic Acid 9%
• Lysophosphatidylcholine 18%
• Phosphatidylethanolamine 18%
• Phosphatidylglycerol 9%
• Phosphatidylinositol 18%
• Phosphatidylserine 9%
• Retention Time 100%
• Rosuvastatin 100%
• Sphingomyelin 18%
• Time-of-Flight Mass Spectrometry 9%

Medicine and Dentistry

• 2 Propanol 12%
• Acetonitrile 25%
• Ammonium Acetate 25%
• Biomembrane 12%
• Chloroform 25%
• Drug Response 25%
• Egg Lecithin 100%
• Hypolipidemic Agent 12%
• Lysophosphatidic Acid 12%
• Lysophosphatidylcholine 25%
• Methanol 25%
• Mobile Phase Composition 25%
• Phosphatidylethanolamine 25%
• Phosphatidylglycerol 12%
• Phosphatidylinositol 25%
• Phosphatidylserine 12%
• Rosuvastatin 100%
• Side Effect 12%
• Sphingomyelin 25%
• Time-of-Flight Mass Spectrometry 12%
• Ultra Performance Liquid Chromatography 12%